☆ 4.7 Article

Engineered TCR T-cell therapy targeting mass spectrometry-identified natural epitope in PDAC

CANCER LETTERS (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Rapid generation of CD19 CAR-T cells by minicircle DNA enables anti-tumor activity and prevents fatal CAR-B leukemia

Xueshuai Ye et al.

Summary: Manufacturing CAR-T cells using viral vectors is expensive and time-consuming, and random integration of genes encoding CARs can lead to oncogenesis or the production of devastating CAR-tumor cells. In this study, we developed a virus-free and non-transgenic mcDNA vector to rapidly generate CD19 CAR-T cells within two days. Furthermore, we demonstrated that the antitumor effects of CD19 CAR-T cells produced by mcDNA are as effective as those produced by viral vectors in vitro and in xenograft models. Our manufacturing process also avoids the production of fatal CAR-tumor cells.

CANCER LETTERS (2023)

添加到收藏夹

Article Oncology

CD8+T cell exhaustion and cancer immunotherapy

Qingda Wang et al.

Summary: Immunotherapy plays a crucial role in treating malignant tumors, and CD8+ T cells are essential for the success of immunotherapy. However, continuous antigen exposure and inflammatory factors can lead to CD8+ T cell exhaustion, causing loss of control and tumor progression. This review provides insights into the mechanisms and characteristics of CD8+ T cell exhaustion. While immunotherapy can reverse exhaustion and improve antitumor effects, single immunotherapy has limitations. The review also highlights promising clues for future management of malignant tumors.

CANCER LETTERS (2023)

添加到收藏夹

Article Oncology

Engaging stemness improves cancer immunotherapy

Hassan Dianat-Moghadam et al.

Summary: Intra-tumoral immune cells promote the stemness of cancer stem cells (CSCs) in the tumor microenvironment, which can play a role in tumor progression, relapse, and resistance to immunotherapy. Stem-like T cells and stem cell-derived NK cells show promising potential in improving the therapeutic efficacy of immunotherapy.

CANCER LETTERS (2023)

添加到收藏夹

Article Oncology

Cancer-associated fibroblasts: Key criminals of tumor pre-metastatic niche

Guozhang Dong et al.

Summary: Cancer-associated fibroblasts (CAFs) play crucial roles in primary tumor by providing support, promoting tumor cell adhesion, remodeling extracellular matrix, and forming cell clusters with circulating tumor cells. Recent studies have focused on the involvement of CAFs in pre-metastatic niche (PMN) formation and prevention of metastasis. This review discusses the role of CAFs in PMN formation and therapeutic interventions targeting PMN and CAFs to prevent metastasis.

CANCER LETTERS (2023)

添加到收藏夹

Article Oncology

Hypoxia induces immunosuppression, metastasis and drug resistance in pancreatic cancers

Huan Zhang et al.

Summary: Pancreatic cancer is a common malignant tumor of the digestive system and is notoriously difficult to diagnose at an early stage. The prognosis for patients is poor due to rapid disease progression and limited effectiveness of chemotherapy and radiotherapy. Research has shown that hypoxia in the microenvironment of pancreatic cancer plays a crucial role in angiogenesis, fibrosis, and immunosuppression, along with the metastasis of the cancer. Further investigation into the hypoxic microenvironment can help elucidate the specific mechanisms of hypoxia in pancreatic cancer and facilitate the development of targeted therapeutic and diagnostic strategies.

CANCER LETTERS (2023)

添加到收藏夹

Article Oncology

IKZF3 deficiency potentiates chimeric antigen receptor T cells targeting solid tumors

Yan Zou et al.

Summary: Knocking out transcription factor IKZF3 enhances the killing effect of CAR T cells on solid tumors, leading to increased T cell activation and proliferation. The strategy of IKZF3 KO may improve the efficacy of CAR T cells in treating solid tumors.

CANCER LETTERS (2022)

添加到收藏夹

Article Oncology

Giant obscurin regulates migration and metastasis via RhoA-dependent cytoskeletal remodeling in pancreatic cancer

Soontorn Tuntithavornwat et al.

Summary: Obscurins, encoded by the OBSCN gene, play a critical role in pancreatic cancer progression and metastasis by regulating cytoskeletal remodeling through RhoA activity. Decreased levels of giant obscurins in pancreatic ductal adenocarcinomas lead to faster cell migration, tumor growth, and metastasis development.

CANCER LETTERS (2022)

添加到收藏夹

Article Oncology

Remodeling metabolic fitness: Strategies for improving the efficacy of chimeric antigen receptor T cell therapy

Luyan Shen et al.

CANCER LETTERS (2022)

添加到收藏夹

Article Oncology

Tumor-derived extracellular vesicles induce invalid cytokine release and exhaustion of CD19 CAR-T Cells

Xiaoying Zhu et al.

Summary: This study reveals that tumor-derived extracellular vesicles (EVs) carrying CD19 antigen can activate CD19 CAR-T cells, but sustained activation leads to exhaustion of CAR-T cells, characterized by upregulation of inhibitory receptors, decreased expansion ability, exaggerated effector cell differentiation, and impaired anti-tumor activity.

CANCER LETTERS (2022)

添加到收藏夹

Article Medicine, General & Internal

Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer

Rom Leidner et al.

Summary: The patient with progressive metastatic pancreatic cancer showed regression of visceral metastases after receiving infusion of genetically engineered autologous T cells targeting mutant KRAS G12D, with an overall partial response of 72% according to the Response Evaluation Criteria in Solid Tumors, version 1.1. The response was ongoing at 6 months, and the engineered T cells accounted for more than 2% of all circulating peripheral-blood T cells.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

添加到收藏夹

Article Oncology

Enhanced AC133-specific CAR T cell therapy induces durable remissions in mice with metastatic small cell lung cancer

Sanaz Taromi et al.

Summary: This study found that combining AC133-specific CAR T cells with PD-1 inhibition and CD73 inhibition can effectively treat metastatic small cell lung cancer, reduce tumor burden, prolong survival, and potentially induce long-term complete remission.

CANCER LETTERS (2022)

添加到收藏夹

Article Oncology

Therapeutic bispecific antibodies against intracellular tumor antigens

Guanghui Xu et al.

Summary: Bispecific antibodies (BsAbs) have shown promise as immunotherapy strategies, but have been limited to targeting cell surface antigens. However, recent attention has been focused on BsAbs that target intracellular oncoproteins, broadening the scope of tumor antigen targeting and improving the effectiveness of antibody-based therapies.

CANCER LETTERS (2022)

添加到收藏夹

Article Oncology

Activation of STING in the pancreatic tumor microenvironment: A novel therapeutic opportunity

Hanane Chamma et al.

Summary: Pancreatic ductal adenocarcinoma (PDAC) is a cancer with poor prognosis and limited response to immunotherapy. Novel strategies targeting the Stimulator of Interferon Genes (STING) protein have shown the potential to elicit response to immunotherapy. However, the effectiveness of STING activation varies depending on the cellular and tissue context, emphasizing the importance of understanding tumor heterogeneity in determining its benefits for PDAC patients.

CANCER LETTERS (2022)

添加到收藏夹

Article Oncology

Single cell RNA-seq reveals the CCL5/SDC1 receptor-ligand interaction between T cells and tumor cells in pancreatic cancer

Kai Chen et al.

Summary: This study characterized the cellular landscape and transcriptional dynamics of T cells in PDAC through single-cell RNA sequencing analysis, identifying interactions between malignant ductal cells and tumor cells. The findings demonstrated that CCL5 promoted tumor cell migration in PDAC by interacting with SDC1.

CANCER LETTERS (2022)

添加到收藏夹

Article Oncology

Neoantigen-targeted TCR-T cell therapy for solid tumors: How far from clinical application

Ruihan Xu et al.

Summary: TCR-T cell therapy targeting neoantigens shows promise for solid tumor immunotherapy. Despite the increasing efficiency and productivity in manufacturing TCR-T cells, clinical-scale production still faces significant challenges. This review summarizes the latest progress in neoantigen-targeted TCR-T cell therapy and discusses the technical difficulties in personalized preparation and the challenges in clinical applications.

CANCER LETTERS (2022)

添加到收藏夹

Article Oncology

The trilogy of P21 activated kinase, autophagy and immune evasion in pancreatic ductal adenocarcinoma

Yi Ma et al.

Summary: Pancreatic Ductal Adenocarcinoma (PDA) is a deadly cancer with KRAS mutation as a common oncogene. P21-activated kinases (PAKs) are downstream mediators of KRAS and play a role in PDA tumorigenesis. Inhibiting PAK reduces cancer cell viability and sensitizes them to chemotherapy. PAK inhibition also increases cancer immunogenicity in melanoma, glioblastoma, and PDA. Autophagy is important in PDA immune evasion and there is a connection between PAK and cancer cell autophagy.

CANCER LETTERS (2022)

添加到收藏夹

Letter Oncology

Direct identification of HLA class I and class II-restricted T cell epitopes in pancreatic cancer tissues by mass spectrometry

Kenji Fujiwara et al.

Summary: This study identified T cell epitopes in PDAC using mass spectrometry and found that these epitopes can be shared by patients with different HLA types. Furthermore, these epitopes induced immune responses in peripheral T cells, suggesting their potential application in both HLA-type matched and non-matched patients.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)

添加到收藏夹

Review Cell & Tissue Engineering

CAR T cells in solid tumors: challenges and opportunities

Faroogh Marofi et al.

Summary: CAR T cells have shown significant advancements in treating blood disorders, but face challenges in solid tumor therapy due to issues with recognition, trafficking, and survival within the tumor. Efforts to overcome these challenges, including addressing the immunosuppressive tumor microenvironment, show promise in reducing T cell exhaustion and improving therapeutic outcomes in non-hematologic malignancies.

STEM CELL RESEARCH & THERAPY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers

Nisha B. Nagarsheth et al.

Summary: In a first-in-human phase 1 trial, T cells targeting HPV-16 E7 showed promising results in treating metastatic epithelial cancers, with objective clinical responses observed in 6 out of 12 patients. This suggests that genetically engineered T cell therapy may be effective in treating common carcinomas, but further studies are needed to understand the resistance mechanisms in advanced epithelial cancer.

NATURE MEDICINE (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Pancreatic cancer cells render tumor-associated macrophages metabolically reprogrammed by a GARP and DNA methylation-mediated mechanism

Mengwen Zhang et al.

Summary: The study revealed that pancreatic ductal adenocarcinoma (PDA) tumor cells induce DNA methylation and downregulation of glucose metabolism genes selectively in M1-like macrophages, leading to their phenotypic reprogramming into M2-like macrophages. This process is mediated by GARP and integrin alpha V/beta 8 and results in the acquisition of pro-cancerous capabilities by M1-like macrophages through Il-10 activation. The research suggests that PDA cells can reprogram M1-like macrophages metabolically and functionally through DNA methylation to adopt a pro-cancerous fate.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma

Jennifer N. Brudno et al.

NATURE MEDICINE (2020)

添加到收藏夹

Review Oncology

Autophagy regulation as a promising approach for improving cancer immunotherapy

Nestor Ishimwe et al.

CANCER LETTERS (2020)

添加到收藏夹

Article Cell & Tissue Engineering

Anti-EGFR chimeric antigen receptor-modified T cells in metastatic pancreatic carcinoma: A phase I clinical trial

Yang Liu et al.

CYTOTHERAPY (2020)

添加到收藏夹

Review Oncology

Engineering CAR-T Cells for Next-Generation Cancer Therapy

Mihe Hong et al.

CANCER CELL (2020)

添加到收藏夹

Article Medicine, General & Internal

Pancreatic cancer

Jonathan D Mizrahi et al.

LANCET (2020)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Phase I Study of Lentiviral-Transduced Chimeric Antigen Receptor-Modified T Cells Recognizing Mesothelin in Advanced Solid Cancers

Andrew R. Haas et al.

MOLECULAR THERAPY (2019)

添加到收藏夹

Article Cell Biology

Phase I study of chimeric antigen receptor modified T cells in treating HER2-positive advanced biliary tract cancers and pancreatic cancers

Kaichao Feng et al.

PROTEIN & CELL (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

Activity of Mesothelin-Specific Chimeric Antigen Receptor T Cells Against Pancreatic Carcinoma Metastases in a Phase 1 Trial

Gregory L. Beatty et al.

GASTROENTEROLOGY (2018)

添加到收藏夹

Review Gastroenterology & Hepatology

Therapeutic developments in pancreatic cancer: current and future perspectives

John P. Neoptolemos et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)

添加到收藏夹

Article Oncology

Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1c259 T Cells in Synovial Sarcoma

Sandra P. D'Angelo et al.

CANCER DISCOVERY (2018)

添加到收藏夹

Article Oncology

CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial

Yao Wang et al.

ONCOIMMUNOLOGY (2018)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Tumor Antigen and Receptor Densities Regulate Efficacy of a Chimeric Antigen Receptor Targeting Anaplastic Lymphoma Kinase

Alec J. Walker et al.

MOLECULAR THERAPY (2017)

添加到收藏夹

Article Medicine, Research & Experimental

CD19 CAR-T cells of defined CD4+: CD8+ composition in adult B cell ALL patients

Cameron J. Turtle et al.

JOURNAL OF CLINICAL INVESTIGATION (2016)

添加到收藏夹

Review Pharmacology & Pharmacy

Chimeric antigen receptor-modified T cells for the treatment of solid tumors: Defining the challenges and next steps

Gregory L. Beatty et al.

PHARMACOLOGY & THERAPEUTICS (2016)

添加到收藏夹

Review Immunology

T Cell Antigen Receptor Recognition of Antigen-Presenting Molecules

Jamie Rossjohn et al.

ANNUAL REVIEW OF IMMUNOLOGY VOL 33 (2015)

添加到收藏夹

Article Oncology

Serum LAMC2 enhances the prognostic value of a multi-parametric panel in non-small cell lung cancer

D. Korbakis et al.

BRITISH JOURNAL OF CANCER (2015)

添加到收藏夹

Article Oncology

T Cells Engineered against a Native Antigen Can Surmount Immunologic and Physical Barriers to Treat Pancreatic Ductal Adenocarcinoma

Ingunn M. Stromnes et al.

CANCER CELL (2015)

添加到收藏夹

Article Biochemistry & Molecular Biology

LAMC2 enhances the metastatic potential of lung adenocarcinoma

Y. W. Moon et al.

CELL DEATH AND DIFFERENTIATION (2015)

添加到收藏夹

Article Oncology

Targeting of HPV-16+ Epithelial Cancer Cells by TCR Gene Engineered T Cells Directed against E6

Lindsey M. Draper et al.

CLINICAL CANCER RESEARCH (2015)

添加到收藏夹

Article Medicine, General & Internal

T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial

Daniel W. Lee et al.

LANCET (2015)

添加到收藏夹

Article Endocrinology & Metabolism

Laminin-5γ-2 (LAMC2) Is Highly Expressed in Anaplastic Thyroid Carcinoma and Is Associated With Tumor Progression, Migration, and Invasion by Modulating Signaling of EGFR

Manoj Garg et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)

添加到收藏夹

Article Multidisciplinary Sciences

Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing

Mahesh Yadav et al.

NATURE (2014)

添加到收藏夹

Article Cell Biology

Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia

Marco L. Davila et al.

SCIENCE TRANSLATIONAL MEDICINE (2014)

添加到收藏夹

Article Oncology

Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies

Gregory L. Beatty et al.

CANCER IMMUNOLOGY RESEARCH (2014)

添加到收藏夹

Article Biochemical Research Methods

Laminin, gamma 2 (LAMC2): A Promising New Putative Pancreatic Cancer Biomarker Identified by Proteomic Analysis of Pancreatic Adenocarcinoma Tissues

Hari Kosanam et al.

MOLECULAR & CELLULAR PROTEOMICS (2013)

添加到收藏夹

Article Oncology

Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1

Paul F. Robbins et al.

JOURNAL OF CLINICAL ONCOLOGY (2011)

添加到收藏夹

Review Multidisciplinary Sciences

Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion

Robert D. Schreiber et al.

SCIENCE (2011)

添加到收藏夹

Article Genetics & Heredity

Enhanced functionality of T cell receptor-redirected T cells is defined by the transgene cassette

Matthias Leisegang et al.

JOURNAL OF MOLECULAR MEDICINE-JMM (2008)

添加到收藏夹

Article Oncology

Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability

Cyrille J. Cohen et al.

CANCER RESEARCH (2006)

添加到收藏夹

Review Biochemistry & Molecular Biology

How the T cell receptor sees antigen - A structural view

KC Garcia et al.

CELL (2005)

添加到收藏夹

Article Multidisciplinary Sciences

IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity

V Shankaran et al.

NATURE (2001)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.